Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangshuo Feng

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Haematologica|May 29, 2025
Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencingLanting Liu, Hao Sun, Fangshuo Feng, et al.
Frontiers in Immunology|October 9, 2024
DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathwaysLanting Liu, Dasen Gong, Hao Sun, et al.
Haematologica|May 30, 2024
LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myelomaLixin Gong, Hao Sun, Lanting Liu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Haematologica|May 29, 2025
Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencingLanting Liu, Hao Sun, Fangshuo Feng, et al.
Frontiers in Immunology|October 9, 2024
DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathwaysLanting Liu, Dasen Gong, Hao Sun, et al.
Haematologica|May 30, 2024
LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myelomaLixin Gong, Hao Sun, Lanting Liu, et al.
Pageof 1